Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 pediatric VTE trial of edoxaban versus standard anticoagulation
MOH_2017-04-03_000290Phase 3Not yet recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of edoxaban in venous thromboembolism (VTE) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Primary endpoint not specified in registry entry. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on MOH_2017-04-03_000290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-04-03_000290.